Hosted by Andrew Miller MP, the ABPI parliamentary event discussion on innovation and commercial success also marked the launch of the spring issue of 'Science in Parliament', which examines current issues and developments in the bio-pharmaceutical sector.
Speaking at the event David Willetts, Minister for Universities and Science, outlined the need for greater innovation across the NHS.
The discussion began with David Willetts outlining the Government’s position of continued support for medical innovation within the NHS and its important role in helping the UK to remain a global hub for life sciences. “The NHS can sometimes be a late adopter. It should be much more prompt in taking on new technologies,” he said. Stephen Whitehead raised the importance of medical innovation and the benefits the NHS receives from new medicines.
Lord Drayson concluded the event with a speech highlighting his own experience in the bio-pharmaceutical industry and the importance of developing a skilled workforce. He described the role of Government as key in developing the best conditions for companies to innovate and commercialise in the UK market.